We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$4.96B
AUM Growth
-$641M
Cap. Flow
-$193M
Cap. Flow %
-3.9%
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$33.6M
2
AMZN icon
Amazon
AMZN
+$32.3M
3
CEB
CEB Inc.
CEB
+$27.7M
4
GILD icon
Gilead Sciences
GILD
+$27.3M
5
MRK icon
Merck
MRK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.16%
2 Financials 16.84%
3 Consumer Discretionary 14.26%
4 Technology 13.32%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWW icon
276
W.W. Grainger
GWW
$62.2B
$919K 0.02%
4,275
+1,456
+52% +$327K
RSPP
277
DELISTED
RSP Permian, Inc.
RSPP
$916K 0.02%
45,252
+9,677
+27% +$228K
PHO icon
278
Invesco Water Resources ETF
PHO
$2.05B
$899K 0.02%
43,756
-2,399
-5% -$54.9K
THS
279
DELISTED
Treehouse Foods
THS
$892K 0.02%
11,470
-4,415
-28% -$354K
ODFL icon
280
Old Dominion Freight Line
ODFL
$41.5B
$884K 0.02%
43,485
-553,494
-93% -$12.6M
VO icon
281
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$878K 0.02%
30,100
+200
+0.7% +$6.24K
IWB icon
282
iShares Russell 1000 ETF
IWB
$49.2B
$875K 0.02%
8,174
-21
-0.3% -$2.38K
BSTC
283
DELISTED
BioSpecifics Technologies Corp.
BSTC
$866K 0.02%
19,880
-8,155
-29% -$440K
IBN icon
284
ICICI Bank
IBN
$107B
$864K 0.02%
113,373
-19,860
-15% -$170K
XNCR icon
285
Xencor
XNCR
$2.15B
$863K 0.02%
70,555
+2,600
+4% +$50.9K
PSX icon
286
Phillips 66
PSX
$95.7B
$860K 0.02%
11,194
+59
+0.5% +$4.69K
CWB icon
287
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.68B
$859K 0.02%
+19,214
New +$892K
LVS icon
288
Las Vegas Sands
LVS
$28.7B
$856K 0.02%
22,531
-1,000
-4% -$50.4K
SCCO icon
289
Southern Copper
SCCO
$183B
$855K 0.02%
34,930
+8,456
+32% +$212K
MNST icon
290
Monster Beverage
MNST
$91.5B
$853K 0.02%
75,780
+3,324
+5% +$39K
NEE icon
291
NextEra Energy
NEE
$174B
$851K 0.02%
34,896
-540
-2% -$13.7K
DOV icon
292
Dover
DOV
$27.2B
$842K 0.02%
18,237
-743
-4% -$37.6K
GIII icon
293
G-III Apparel Group
GIII
$1.41B
$841K 0.02%
13,640
+6,120
+81% +$420K
INCY icon
294
Incyte
INCY
$25.9B
$820K 0.02%
7,433
+450
+6% +$50.5K
NFLX icon
295
Netflix
NFLX
$332B
$810K 0.02%
78,490
-29,800
-28% -$320K
BAX icon
296
Baxter International
BAX
$13.4B
$806K 0.02%
24,549
-50,017
-67% -$1.89M
WY icon
297
Weyerhaeuser
WY
$17.1B
$796K 0.02%
29,112
-2,425
-8% -$71.6K
EXAM
298
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$796K 0.02%
27,221
+9,855
+57% +$340K
PANW icon
299
Palo Alto Networks
PANW
$312B
$783K 0.02%
27,300
-17,400
-39% -$513K
BRK.A icon
300
Berkshire Hathaway Class A
BRK.A
$1.08T
$781K 0.02%
4
+1
+33% +$206K

Similar funds

Geneva Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.

  • Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
  • Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
  • Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
  • Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
  • Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
  • Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
  • Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.

Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.